Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Latin America
6.2 By Country
7 Industry Opportunities and Challenges
8 Latin America Active Pharmaceutical Ingredients (APIs) Market Analysis
8.1 Key Industry Highlights
8.2 Latin America Active Pharmaceutical Ingredients (APIs) Historical Market (2019-2025)
8.3 Latin America Active Pharmaceutical Ingredients (APIs) Market Forecast (2026-2035)
8.4 Latin America Active Pharmaceutical Ingredients (APIs) Market by Drug Type
8.4.1 Innovative Active Pharmaceutical Ingredients
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2019-2025)
8.4.1.3 Forecast Trend (2026-2035)
8.4.2 Generic Active Pharmaceutical Ingredients
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2019-2025)
8.4.2.3 Forecast Trend (2026-2035)
8.5 Latin America Active Pharmaceutical Ingredients (APIs) Market by Type of Manufacturer
8.5.1 Captive Manufacturers
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2019-2025)
8.5.1.3 Forecast Trend (2026-2035)
8.5.2 Merchant API Manufacturers
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2019-2025)
8.5.2.3 Forecast Trend (2026-2035)
8.6 Latin America Active Pharmaceutical Ingredients (APIs) Market by Synthesis Type
8.6.1 Synthetic Active Pharmaceutical Ingredients
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2019-2025)
8.6.1.3 Forecast Trend (2026-2035)
8.6.1.4 Market by Type
8.6.1.4.1 Innovative Synthetic APIs
8.6.1.4.2 Generic Synthetic APIs
8.6.2 Biotech Active Pharmaceutical Ingredients
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2019-2025)
8.6.2.3 Forecast Trend (2026-2035)
8.6.2.4 Market by Type
8.6.2.4.1 Biosimilars
8.6.2.4.2 Innovative Biotech APIs
8.6.2.5 Market by Product
8.6.2.5.1 Monoclonal Antibodies
8.6.2.5.2 Cytokines
8.6.2.5.3 Vaccines
8.6.2.5.4 Therapeutic Enzymes
8.6.2.5.5 Fusion Proteins
8.6.2.5.6 Blood Factors
8.6.2.6 Market by Expression System
8.6.2.6.1 Mammalian Expression Systems
8.6.2.6.2 Microbial Expression Systems
8.6.2.6.3 Yeast Expression Systems
8.6.2.6.4 Transgenic Animal Systems
8.6.2.6.5 Others
8.7 Latin America Active Pharmaceutical Ingredients (APIs) Market by Therapeutic Area
8.7.1 Oncology
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2019-2025)
8.7.1.3 Forecast Trend (2026-2035)
8.7.2 Cardiovascular and Respiratory
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2019-2025)
8.7.2.3 Forecast Trend (2026-2035)
8.7.3 Diabetes
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2019-2025)
8.7.3.3 Forecast Trend (2026-2035)
8.7.4 Central Nervous System Disorders
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2019-2025)
8.7.4.3 Forecast Trend (2026-2035)
8.7.5 Neurological Disorders
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2019-2025)
8.7.5.3 Forecast Trend (2026-2035)
8.7.6 Others
8.8 Latin America Active Pharmaceutical Ingredients (APIs) Market by Country
8.8.1 Market Share
8.8.1.1 Brazil
8.8.1.2 Argentina
8.8.1.3 Chile
8.8.1.4 Mexico
8.8.1.5 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Argentina
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
9.3 Chile
9.3.1 Historical Trend (2019-2025)
9.3.2 Forecast Trend (2026-2035)
9.4 Mexico
9.4.1 Historical Trend (2019-2025)
9.4.2 Forecast Trend (2026-2035)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Manufacturing Process
12.1 Product Overview
12.2 Raw Material Requirements
12.3 Manufacturing Process
12.4 Key Success and Risk Factors
13 Competitive Landscape
13.1 Market Structure
13.2 Key Company Profiles
13.2.1 Company Overview
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Certifications
14 Industry Events and Developments